ArticlebioRxiv : the preprint server for biology2026
Selective impairment of long-term depression in accumbal D1-MSNs involves calcium-permeable AMPARs in Alzheimer's disease.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
8 authors.
Funding
Abstract
Early neuropsychiatric symptoms in Alzheimer's disease emerge before cognitive decline, yet their synaptic basis remains poorly defined. Here we identify an early, cell-type-specific disruption of synaptic plasticity in the nucleus accumbens during pre-plaque stages of disease. In APP/PS1 mice, intracellular amyloid-beta accumulation is associated with a selective loss of mGluR1/5-dependent long-term depression in dopamine D1 receptor-expressing medium spiny neurons, despite comparable intracellular amyloid-beta levels across neuronal subtypes. This impairment is accompanied by aberrant postsynaptic remodeling characterized by functional accumulation of calcium-permeable AMPA receptors and increased excitatory drive. These synaptic alterations coincide with reduced dopamine-dependent signaling and selective changes in reward-related behavior, including altered hedonic consumption. Together, these findings identify an early vulnerability of the mesolimbic reward system and suggest that non-cognitive manifestations of Alzheimer's disease arise from circuit-level imbalance before plaque deposition.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.